Gut bacteria transplant shows promise for recurring UTIs
NCT ID NCT07627412
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether transplanting healthy gut bacteria (washed microbiota transplantation) could help people who get frequent urinary tract infections (UTIs). Thirty adults with recurrent UTIs received the treatment through a tube into the gut. Researchers tracked how many UTIs occurred over the next year to see if the transplant reduced infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
30 people
The number who actually took part.
- Started
-
Aug 2022
- Finished
-
Aug 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥18 years, both sexes. 2. Meeting the diagnostic criteria for recurrent urinary tract infection: ≥2 symptomatic UTI episodes within 6 months or ≥3 episodes within 1 year. 3. Planning to receive washed microbiota transplantation (WMT) treatment. 4. Able to provide informed consent and comply with scheduled follow-up visits, examinations, and specimen collection. Exclusion Criteria: 1. Received antimicrobial therapy within 48 hours before WMT. 2. Complicated UTI requiring surgical intervention, including urinary tract tumor, stricture, congenital malformation, or neurogenic bladder. 3. Co-infection with other urogenital pathogens including fungi, viruses, Mycoplasma, or Chlamydia. 4. Unable to tolerate gastroscopy or colonoscopy for TET tube placement. 5. Severe comorbidities involving heart, liver, kidney, hematopoietic system, respiratory system, or endocrine system that may affect survival, or other serious diseases affecting survival. 6. Pregnant or lactating women. 7. Coexisting psychiatric disorders. 8. Other conditions deemed unsuitable for enrollment by the investigator.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Recurrent urinary tract infections are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Microbiota Medicine & Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria transplant tested against Antibiotic-Resistant urinary infections
- Why do some complicated UTIs resist treatment? massive study aims to find out
- Could removing catheters sooner after kidney transplant cut infections?
- Can better school toilets and peer support boost girls' health and grades? a madagascar trial aims to find out.
- Antibiotic levels in breast milk under the microscope
- Can antibiotic wash and suction stop Post-Surgery infections?